Tech Company Financing Transactions
Amplifica Funding Round
Amplifica closed a $26 million Series B venture capital round on 8/12/2026. Investors included Eli Lilly and Company and private investors.
Transaction Overview
Company Name
Announced On
8/12/2026
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance the clinical development of its pipeline candidates designed to reactivate dormant hair follicles and promote the growth of new hair.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
17140 Bernardo Center Dr. 354
San Diego, CA 92128
USA
San Diego, CA 92128
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Amplifica is a biopharmaceutical company focused on developing novel treatments to address androgenic alopecia (hair loss), a condition estimated to affect over 50 million men and over 30 million women in the United States alone. The Company has identified and isolated unique signaling molecules that stimulate hair follicles to regrow hair.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Wajdie Ahmad
Chief Executive Officer
Frank Fazio
Chief Medical Officer
William Rassman
Chief Scientific Officer
Maksim Plikus
Browse more venture capital transactions:
Prev: 8/12/2026: Cytix venture capital transaction
Next: 8/12/2026: CodeRabbit venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document all VC transactions involving tech companies. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs